SAB Biotherapeutics to present SAB-142 data at ADA Scientific Sessions
PUBT · 05/29 12:02
Share
Listen to the news
- SAB Biotherapeutics will present SAB-142 repeat-dosing data at the American Diabetes Association’s 2026 Scientific Sessions on June 5-8, 2026.
- The ADA oral presentation is scheduled for June 5, 2026, in New Orleans.
- Additional SAB-142 data will be shown at the FOCIS 2026 Annual Meeting on June 9-12, 2026.
- The FOCIS poster presentation is scheduled for June 10, 2026, in San Francisco.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SAB Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605290800PRIMZONEFULLFEED9728359) on May 29, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending